First humans receive experimental drug TAK-004 in safety test
NCT ID NCT06236009
Summary
This was the first study to give the experimental drug TAK-004 to people. Its main goal was to check if the drug is safe and well-tolerated in healthy adults. Researchers also measured how the body processes the drug and if it affects heart rate or blood pressure. The study involved 121 healthy volunteers who received either TAK-004 or a placebo injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.